Artacil Inj is a non-depolarizing neuromuscular blocking agent used during surgery, anesthesia, and mechanical ventilation to induce controlled muscle relaxation. It belongs to a class of medications that work by blocking the transmission of nerve impulses to the muscles, resulting in temporary muscle paralysis — essential for smooth surgical procedures and endotracheal intubation.

This medicine is administered intravenously (IV) by trained healthcare professionals in a hospital or ICU setting. Atracurium Besylate acts quickly and has an intermediate duration of action, making it suitable for short to medium-length surgeries.

A key advantage of Atracurium Besylate is its unique metabolism via Hofmann elimination, which is independent of liver or kidney function. This ensures predictable effects and safer use in patients with hepatic or renal impairment.